Navigation Links
SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
Date:8/7/2008

out the merger. The proxy statement and other relevant materials, and any other documents filed by SGX with the SEC, may be obtained free of charge at the SEC's website at http://www.sec.gov. In addition, investors and stockholders may obtain free copies of the documents filed with the SEC by going to SGX's Investor Relations page on its corporate website at http://www.sgxpharma.com or by directing a written request to SGX at 10505 Roselle Street, San Diego, California 92121 -- Attention: Corporate Secretary.

Participants in the Solicitation

SGX and its directors and executive officers may be deemed to be participants in the solicitation of proxies from SGX stockholders in connection with the merger. Certain directors and executive officers of SGX may have direct or indirect interests in the merger due to, among other things, securities holdings, pre-existing or future indemnification arrangements, vesting of equity awards, or rights to severance payments in connection with the merger. Additional information regarding the directors and executive officers of SGX and their interests in the merger is contained in the definitive proxy statement that SGX filed with the SEC.

Forward Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements include, but are not limited to, statements related to research and development programs, the proposed merger transaction, including whether the merger transaction will be approved by SGX's stockholders, whether the other conditions to closing of the proposed transaction will be met and if any of the potential benefits of the proposed merger will be realized, the potential of the Company's inhibitors as treatments for certain cancers, and the ability to discover, develop, build a pipeline of and commercialize cancer therapeuti
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. Memory Pharmaceuticals to Announce Second Quarter 2008 Results on Wednesday, August 13, 2008
4. Watson Pharmaceuticals Reports Second Quarter 2008 Results
5. Onyx Pharmaceuticals Reports Second Quarter and Six-Month 2008 Financial Results
6. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
7. Marinus Pharmaceuticals Appoints John Krayacich as President and Chief Executive Officer
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008
9. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
10. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
11. Anacor Pharmaceuticals Appoints Dr. Kurt Jarnagin Vice President of Biological Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (MIPT and Russian Quantum Center at Skolkovo) and ... and the Institute of Physics in Bratislava, Slovakia) ... of particles passing through an amplifier and, conversely, ... are provided in an article published in the ... , Quantum entangled particles are considered to be ...
(Date:7/23/2014)... 2014 Last year, Formedix ... leading global provider of data management solutions for clinical ... leading-edge system for electronic data capture (EDC) and clinical ... and study execution tools added TrialMaster to its Transform ... version of Transform for TrialMaster, is being released this ...
(Date:7/23/2014)... July 23, 2014 DuPont Pioneer announced ... as vice president of Agricultural Biotechnology (ABT), effective July ... he served most recently as president, chief executive officer ... business leadership in the seed and crop protection industry ... Paul E. Schickler , president of DuPont Pioneer. “I ...
(Date:7/23/2014)... , July 23, 2014  Sofinnova Ventures, a ... announced the closing of Sofinnova Venture Partners IX, L.P. ... excess of the initial fund target of $425 million. ... successful biotechnology companies. Consistent with recent funds, SVP IX ... stage clinical programs, along with select investments in earlier ...
Breaking Biology Technology:Scientists find way to maintain quantum entanglement in amplified signals 2Scientists find way to maintain quantum entanglement in amplified signals 3Scientists find way to maintain quantum entanglement in amplified signals 4Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Sofinnova Raises $500 Million Biotech Venture Fund 2
... WOBURN, Mass., April 7, 2011 The Center for Business ... to the American Red Cross in support of the relief ... employees made personal contributions to the fund while the organization ... the compassion and generosity CBI employees have displayed to help ...
... Fla. April 5, 2011 A new drug is ... an inherited predisposition to the disease. These patients with ... which can become locally invasive or metastatic, according to a ... at the 102nd annual meeting of the American Association for ...
... (Nasdaq: CEPH ) has scheduled its regular quarterly ... p.m. EDT on Tuesday, May 3, 2011. May 3, ... be distributed by PRNewswire4:50 p.m. EDT , To participate in ... 67208985:00 p.m. EDT , Conference call begins promptly. Simultaneous ...
Cached Biology Technology:The Center for Business Intelligence Donates to the American Red Cross, Matching Employee Contributions for Disaster Relief in Japan 2New drug is effective against the most common form of skin cancer 2
(Date:7/23/2014)... NY -- The potential for clinical use of ... therapeutic strategies has previously been hindered by the ... of tumors. The ability to use etoposide treatment ... treatment of heart disease, specifically acute myocardial infarction, ... Cells and Development , a peer-reviewed journal from ...
(Date:7/23/2014)... WELLESLEY, Massachusetts , July 23, 2014 ... reveals in its new report, GLOBAL MARKETS AND ... and related technologies is expected to grow to nearly ... growth rate (CAGR) of 10.1%. The image, flow, and ... CAGR.      (Logo: http://photos.prnewswire.com/prnh/20140723/694805 ) , ...
(Date:7/23/2014)... This news release is available in German . ... use varying sensory modalities for orientation, some of which ... for example take the polarization pattern produced by sunlight ... researchers from the Max Planck Institute for Ornithology in ... colleagues from Israel that a night active mammal, the ...
Breaking Biology News(10 mins):Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 2Global Market for Sensors to Reach Nearly $154.4 Billion in 2020; Image Sensors Moving at 11.7% 3Bats use the evening sky's polarization pattern for orientation 2
... Building Components (UHGBC), a program in the Gerald D. ... Expo. This event showcases the work of faculty-led research ... and sustainable technologies for the built environment. The ... the College of Architecture,s atrium. The event is free ...
... If Guinness World Records had a category for the largest ... just claimed it. They have designed and successfully ... manufacture the essential amino acid histidine. It is more than ... created by researchers at the University of Washington in 2003. ...
... study conducted by researchers at the Johns Hopkins Malaria ... of drug resistance in malaria-causing parasites taken from both ... human blood samples showed a high prevalence for pyrimethamine-resistance, ... used to treat malaria in the region. However, parasites ...
Cached Biology News:UH Green Building Components Expo showcasing eco-friendly projects 2Creation of the largest human-designed protein boosts protein engineering efforts 2Creation of the largest human-designed protein boosts protein engineering efforts 3Contrasting patterns of malaria drug resistance found between humans and mosquitoes 2
Request Info...
... blotted protein on PVDF membrane or with ... N-terminal sequence of proteins (5-20 residues) can ... HPLC or mono-and bidimensional SDS-PAGE, followed by ... the well known EDMAN degradation method. Pre-treatment ...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
ELF® 97 Immunohistochemistry Kit...
Biology Products: